Shirley A. Rozeboom - 30 Mar 2026 Form 4 Insider Report for HAWKINS INC (HWKN)

Reporting relationship: VP HEALTH AND NUTRITION
Issuer ticker: HWKN
Reported as of: 30 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2026, 16:12:57 UTC
Prior SEC filing: 16 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Joshua L. Colburn, Attorney-in-Fact

Key filing fact

Shirley A. Rozeboom filed Form 4 for HAWKINS INC (HWKN) on 15 May 2026.

Key facts

This page summarizes Shirley A. Rozeboom's Form 4 filing for HAWKINS INC (HWKN).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2026, 16:12.

Change

Previous filing in this sequence was filed on 16 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001776928 Primary reporting owner

Rozeboom Shirley A.

Relationship: VP HEALTH AND NUTRITION
Address: 2381 ROSEGATE, ROSEVILLE
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Signature date: 15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HWKN transaction

Common Stock

Tax liability

Transaction value
Shares: -3,608
Change %: -10%
Price: $151.62^*
Shares after: 31,959
Date: 30 Mar 2026
Ownership: Direct

HWKN transaction

Common Stock

Award

Transaction value
Shares: +1,906
Change %: +5.9%
Price: $0.000000^*
Shares after: 34,088
Date: 13 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Shirley A. Rozeboom is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Includes 194 shares acquired June 2025-December 2025 pursuant to the Issuer's dividend reinvestment plan and 28.5851 shares acquired June 2025-February 2026 pursuant to the Issuer's employee stock purchase plan.